Our last five annual reports, combined into a single review of research, education and clinical service.
Headline figures from the most recent report, with direction of travel since the year before.
Funding and people from 2021 through 2025 — the long arc behind the single-year headlines.
Research awards received into department accounts, by source. US & foreign funding has grown every year since 2022, and 2025 set a new high of $31.4M — Foundations $12.65M, Federal (Tri-Agency) $9.10M, US/Foreign $6.69M, Provincial $2.73M, Industry $0.20M.
Grand-total department funds, all categories (research awards are cross-listed within this total). 2025 reached $47.9M — the highest of the five years.
Appointed faculty roster, up from 420 to 498 over five years (+19%). Clinical faculty are the main driver of this growth — rising from roughly 295 to about 359 (+64 members), the large majority of the increase, reflecting expanded clinical service across the province.
Total financial activity (the department's full financial portfolio: department funds + research funds + personnel awards, as itemized in each annual report). 2024 ($70.6M) and 2025 ($82.4M, ▲16.8%) match the published figures exactly;
Each annual report gets its own spread. Click the cover to open, then flip through like reading.
2021 – 2025 — five years of research, education and clinical service, bound in one volume.
We are an inclusive Department of Pathology and Laboratory Medicine where cutting-edge discoveries are made, future leaders in medicine are trained, and patients receive the highest quality of care.
Transform laboratory medicine and our understanding of disease for better health.
These achievements are not isolated successes — they are the result of a shared vision, a collaborative culture, and the tireless pursuit of excellence.— Department of Pathology & Laboratory Medicine, Annual Report 2024